Records containing: HIV Infections
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2012-01-20Predictors of Drug Hypersensitivity in HIV Infected Subjects
-
CLINICAL_TRIALS study record update · 2012-01-19A Multilevel HIV Prevention Strategy for High-Risk Youth
-
CLINICAL_TRIALS study record update · 2012-01-19A Randomised, Double Blind, Double Dummy, Parallel Group, Active Controlled Trial to Evaluate the Antiviral Efficacy of 400 mg QD neVirapine Extended Release Formulation in Comparison to 200 mg BID neVirapinE Immediate Release in Combination With Truvada® in Antiretroviral Therapy naïve HIV-1 Infected Patients (VERxVE)
-
CLINICAL_TRIALS study record update · 2012-01-19Maintaining Options for Mothers Study (MOMS): A Phase II Randomized Comparison of Three Antiretroviral Strategies Administered for 7 or 21 Days to Reduce the Emergence of Nevirapine Resistant HIV-1 Following a Single Intrapartum Dose of Nevirapine
-
CLINICAL_TRIALS study record update · 2012-01-16Phase II Safety and Immunogenicity Study of Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) L1 Virus-Like Particle (VLP) Vaccine in HIV Infected Children 7 to 12 Years of Age
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2012-01-12Measurement of Adherence to ART in HIV-Infected School-Aged Children in Uganda
-
CLINICAL_TRIALS study record update · 2012-01-06A Phase 2, One Arm, Open Label, Feasibility Study Assessing One Month Zidovudine/Didanosine Postpartum Prophylaxis to Prevent Resistance Mutations in Mothers Exposed to Single Dose Nevirapine to Prevent Mother to Child Transmission of HIV
-
CLINICAL_TRIALS study record update · 2012-01-06A Phase III, Randomized, Non-inferiority Trial Comparing the Standard Viral Load Based Antiretroviral Monitoring Strategy With a CD4 Based Monitoring Strategy Among Antiretroviral Naive Immunocompromised Adults in Thailand
-
CLINICAL_TRIALS study record update · 2012-01-04Reduction of Medical Complications Associated With Injection Drug Use
-
CLINICAL_TRIALS study record update · 2011-12-22Therapeutic Intensification for HIV-associated Non-Hodgkin's Lymphoma by Autologous Transplantation of Either Unselected or CD34+-Selected Peripheral Blood Stem Cells, in Patients in First or Second Complete Remission. ANRS 131
-
CLINICAL_TRIALS study record update · 2011-12-16A Randomized, Double-blind, Placebo-controlled Crossover Trial of Acyclovir for Suppression of HSV and HIV Shedding in HIV-1, HSV-2 Coinfected Persons in Cameroon
-
CLINICAL_TRIALS study record update · 2011-12-14A Double-blind, Randomized, Placebo-Controlled Phase I/II Study to Evaluate the Safety and Acceptability of Dapivirine Gel 4789, 0.05%, 2.5g, a Vaginal Microbicide, Conducted Using Daily Monitored Adherence in Healthy, HIV-Negative Women.
-
CLINICAL_TRIALS study record update · 2011-12-05HAART Regimen Comprising 3TC + ddI + EFV in Once-daily Administration in HIV-1 Infected Children in Burkina Faso
-
CLINICAL_TRIALS study record update · 2011-11-22Efavirenz-based Versus Nevirapine-based Antiretroviral Therapy Among HIV-infected Patients Receiving Rifampin
-
CLINICAL_TRIALS study record update · 2011-11-21A Phase IV, Open-label, Prospective Observational Study to Evaluate Virological Response in Antiretroviral-Experienced HIV 1 Infected Subjects Switching to Atripla (Efavirenz/Emtricitabine/Tenofovir DF) on an Empty Stomach
-
CLINICAL_TRIALS study record update · 2011-11-17Initiation of a Once Daily Regimen of Tenofovir, Lamivudine and Efavirenz After 4 Weeks Versus 12 Weeks of Tuberculosis Treatment in HIV-1 Infected Patients (Time Study)
-
CLINICAL_TRIALS study record update · 2011-11-11Targeted Social Network HIV Prevention Intervention
-
CLINICAL_TRIALS study record update · 2011-11-08Efficacy of Thrice Weekly Intermittent Short Course Antituberculosis Chemotherapy in Tuberculosis Patients With and Without HIV Infection
-
CLINICAL_TRIALS study record update · 2011-11-07An Open-Label, Multicenter, Mechanism Validation Study to Evaluate the Safety, Efficacy and Tolerability of KP-1461 as Monotherapy for 124 Days in Antiretroviral-experienced, HIV-1-infected Subjects
-
CLINICAL_TRIALS study record update · 2011-11-02A 48-week, Randomized, Open-label, 2-arm Study to Compare the Efficacy of Saquinavir/Ritonavir Twice Daily (BID) Plus Emtricitabine/Tenofovir Once Daily (QD) Versus Lopinavir/Ritonavir BID Plus Emtricitabine/Tenofovir QD in Treatment-naïve Human Immunodeficiency Virus Type 1 (HIV-1) Infected Patients (GEMINI Study)
-
CLINICAL_TRIALS study record update · 2011-11-01Randomised, Placebo Controlled, Phase IV, Safety and Exploratory Immunogenicity Study on Maraviroc, an Oral ART CCR5 Inhibitor, on the Intensification of Immune Function in HIV-1 Infected Subjects Receiving Immunisation With Novel Antigens
-
CLINICAL_TRIALS study record update · 2011-10-31Interactions Between Antiretrovirals and Combined Oral Contraceptive Pills
-
CLINICAL_TRIALS study record update · 2011-10-28Raltegravir Substitution for Enfuvirtide in Patients Suffering From Injection Site Reactions (ISRs): The Raleve Pilot Study
-
CLINICAL_TRIALS study record update · 2011-10-2510493 - MK-0518 Intensification and HDAC Inhibition in Depletion of Resting CD4+ T Cell HIV Infection
-
CLINICAL_TRIALS study record update · 2011-10-17A Multicenter, Open Label, Expanded Access Trial Of Maraviroc